Zobrazeno 1 - 10 of 71 pro vyhledávání: '"Johannes P. van Hooff"'
1
Influence of CYP3A5 Genetic Polymorphism on Long-Term Renal Function in Chinese Kidney Transplant Recipients Using Limited Sampling Strategy and Abbreviated Area Under the Curve for Tacrolimus Monitoring
Autor: Koon Ming Chan, Yuen Ting Wong, Johannes P. van Hooff, Wai Leung Chak, Chi Yuen Cheung, Otto Bekers
Publikováno v: Progress in Transplantation, 30(3):1526924820933823, 249-253. SAGE Publications Inc.
Introduction: Although the association between CYP3A5 gene polymorphism and tacrolimus dosing requirements was well established, the impact on how CYP3A5 genotype affects the acute rejection and long-term renal function in patients who received kidne
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::613370709791ec55c8d03ccdcb41f3f9
https://doi.org/10.1177/1526924820933823
Zobrazit plný text záznamu
2
Ten-years data of the first European clinical experience with once-daily tacrolimus extended release formulation in renal transplant recipients
Autor: M Mullens, Johannes P. van Hooff, M. Gelens, M. H. L. Christiaans
Publikováno v: Internal Medicine Review, 3(5), 1-10
Background: Clinical data about long-term use of tacrolimus QD are lacking. Methods: Ten-years data were collected from 37 renal transplant recipients participating in a Tacrolimus BID (Prograf®) to QD (Advagraf®) conversion study. They were conver
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d0089b45ab9c32a9f48139f94516054
https://doi.org/10.18103/imr.v3i5.478
Zobrazit plný text záznamu
3
Impact of CYP3A5 Genetic Polymorphism on Intrapatient Variability of Tacrolimus Exposure in Chinese Kidney Transplant Recipients
Autor: Chi Yuen Cheung, Otto Bekers, Johannes P. van Hooff, Koon Ming Chan, Wai Leung Chak, Yuen Ting Wong
Publikováno v: Transplantation Proceedings, 51(6), 1754-1757. Elsevier Science
Background. Although high tacrolimus (FK) intrapatient variability (IPV) was shown to be associated with poor graft outcome in kidney transplant recipients (KTRs), it is uncertain whether there is any association between the CYP3A5 genotype and IPV o
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c160b3fb8c3d6bcb2093cc7fa39a985
https://pubmed.ncbi.nlm.nih.gov/31255354
Zobrazit plný text záznamu
4
No evidence for progressive deterioration in stimulated insulin secretion in renal transplant recipients after 12years tacrolimus exposure
Autor: M. Gelens, Len A. Usvyat, Johannes P. van Hooff, Maarten H. L. Christiaans
Publikováno v: Journal of Diabetes and Its Complications, 31(9), 1384-1388. Elsevier Science
Aims: Tacrolimus (Tac) inhibits insulin secretion in a Tac-trough blood level dependent way early post-transplant in renal transplant recipients (Rtx). It is unknown whether long-term exposure results into a progressive beta cells dysfunction.Methods
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70d3003f1ce330795d59412d940b7640
https://pubmed.ncbi.nlm.nih.gov/28720321
Zobrazit plný text záznamu
5
Effect of Breakfast on the Exposure of the Once-Daily Tacrolimus Formulation in Stable Kidney Transplant Recipients
Autor: Frank Stifft, Johannes P. van Hooff, Maarten H. L. Christiaans, Nasrullah Undre
Publikováno v: Therapeutic Drug Monitoring, 38(4), 456-462. LIPPINCOTT WILLIAMS & WILKINS
Background:The once-daily Tacrolimus formulation (Tac ONCE-DAILY) has to be taken on an empty stomach. This is inconvenient for patients and may hamper compliance. The influence of food intake on the exposure of Tac ONCE-DAILY is unknown in transplan
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a750d3dd86db2279f352664f326f862
https://pubmed.ncbi.nlm.nih.gov/27128604
Zobrazit plný text záznamu
6
Pharmacokinetics in Stable Kidney Transplant Recipients After Conversion From Twice-Daily to Once-daily Tacrolimus Formulations
Autor: M Rafique Moosa, Johannes P. van Hooff, Carmen Karpf, Derek Miller, Shabbir Dawood, Isak Van der Walt, Maarten H. L. Christiaans, Nasrullah Undre, Jeffrey Kallmeyer
Publikováno v: Therapeutic Drug Monitoring. 34:46-52
BACKGROUND A prolonged-release formulation of tacrolimus for once-daily administration (Tacrolimus QD) has been developed to offer potential improvements in patient adherence. This study compared the pharmacokinetics (PK) of tacrolimus in stable kidn
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b834e6afba725ea8c68b4f19c56be59
https://doi.org/10.1097/ftd.0b013e318244a7fd
Zobrazit plný text záznamu
7
Renal function and safety in stable kidney transplant recipients converted from immediate-release to prolonged-release tacrolimus
Autor: José M. Morales, Johannes P. van Hooff, Ricardo Lauzurica
Publikováno v: Transplant International. 25:48-55
This multicenter, open, phase IIIb study assessed short-term efficacy, safety and dose adjustments in adult stable renal transplant recipients converted from tacrolimus twice-daily (BID) to once-daily (QD). Patients receiving unchanged tacrolimus BID
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bc0b608cc37d6500964ff0891fe84ec2
https://doi.org/10.1111/j.1432-2277.2011.01366.x
Zobrazit plný text záznamu
8
Four-year experience with tacrolimus once-daily prolonged release in patients from phase II conversion and de novo kidney, liver, and heart studies
Autor: Michel Mourad, Rita R. Alloway, Johannes P. van Hooff, Pavel Trunečka
Publikováno v: Clinical Transplantation. 25:E1-E12
This study assessed the long-term effects of prolonged-release tacrolimus (Advagraf(®) [Tacrolimus QD]), which has been developed to provide similar efficacy and safety to twice-daily tacrolimus (Prograf(®) [Tacrolimus BID]) with the added benefit
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ca564a24206f48552fefb6b68ba506d5
https://doi.org/10.1111/j.1399-0012.2010.01377.x
Zobrazit plný text záznamu
9
Pre-kidney-transplant blood transfusions do not improve transplantation outcome: a Dutch national study
Autor: Maarten H. L. Christiaans, Johan W. de Fijter, Jaap J. Homan van der Heide, Ella M. van den Berg-Loonen, Frederike J. Bemelman, R. J. Hene, Henderikus G. Otten, Andries J. Hoitsma, Willem Weimar, Wil A. Allebes, Jeroen Aalten, Johannes P. van Hooff, Frans H.J. Claas, Bouke G. Hepkema, N M Lardy, Simon P. M. Lems
Publikováno v: Nephrology Dialysis Transplantation, 24(8), 2559-2566. Oxford University Press
Nephrology Dialysis Transplantation, 24(8), 2559. Oxford University Press
Nephrology, Dialysis, Transplantation, 24, 2559-66
Nephrology, dialysis, transplantation, 24(8), 2559-2566. Oxford University Press
Nephrology, Dialysis, Transplantation, 24, 8, pp. 2559-66
Contains fulltext : 81930.pdf (Publisher’s version ) (Closed access) BACKGROUND: Female renal transplant candidates are prone to be sensitized by prior pregnancies, and undetected historical sensitization might decrease transplantation outcome. Hyp
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ea008931a8a171ee75525308691a492
https://doi.org/10.1093/ndt/gfp233
Zobrazit plný text záznamu
10
Glucose metabolism before and after conversion from cyclosporine microemulsion to tacrolimus in stable renal recipients
Autor: Maarten H. L. Christiaans, M. Gelens, Johannes P. van Hooff
Publikováno v: Nephrology Dialysis Transplantation, 23(2), 701-706. Oxford University Press
BACKGROUND: Tacrolimus is more diabetogenic than cyclosporine. However, this difference is only discernible in the first few months after renal transplantation. In randomized trials, investigating the effects of immunosuppression after renal transpla
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17421ec18befa4d81a80675639828a40
https://doi.org/10.1093/ndt/gfm544
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje